You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tamoxifen

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

Recruiting
  • Atypical Hyperplasia
  • Lobular Carcinoma in Situ
  • Tamoxifen
  • +2 more
  • Evanston, Illinois
  • +1 more
Jan 20, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

Not yet recruiting
  • Breast Atypical Hyperplasia
  • +3 more
  • Acolbifene Hydrochloride
  • +4 more
  • Duarte, California
  • +3 more
Jul 11, 2023

Vulvar Atrophy Trial in Adelaide, Nedlands (Tamoxifen, Placebo)

Active, not recruiting
  • Vulvar Atrophy
  • Tamoxifen
  • Placebo
  • Adelaide, Southern Australia, Australia
  • +1 more
Dec 6, 2022

Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tamoxifen
  • Tampa, Florida
  • +1 more
Jan 13, 2023

Duchenne Muscular Dystrophy Trial (Tamoxifen)

Completed
  • Duchenne Muscular Dystrophy
  • Tamoxifen
  • (no location specified)
Jul 21, 2022

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting
  • Hypertension
  • +8 more
  • Tamoxifen
  • Placebo Oral Tablet
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 22, 2022

Breast Cancer Trial in Worldwide (GDC-0032, Tamoxifen)

Completed
  • Breast Cancer
  • Paris, France
  • +13 more
Oct 11, 2022

Duchenne Muscular Dystrophy Trial in Worldwide (Tamoxifen, Matching )

Completed
  • Duchenne Muscular Dystrophy
  • Tamoxifen
  • Matching placebo
  • Garches, France
  • +10 more
Dec 19, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Mar 7, 2023

Breast Cancer, Early Breast Cancer Trial (Camizestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Cancer, Early Breast Cancer
  • (no location specified)
Jul 11, 2023

Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 28, 2022

Infertility Trial in San Francisco (Tamoxifen, Letrozole)

Recruiting
  • Infertility
  • San Francisco, California
    University of California at San Francisco
Apr 29, 2022

Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

Not yet recruiting
  • Ductal Carcinoma in Situ
  • Tamoxifen
  • +5 more
  • (no location specified)
Oct 13, 2023

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Tamoxifen
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 13, 2022

Ovarian Cancer Trial in Sydney (SUBA-itraconazole, Tamoxifen)

Not yet recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
    Kinghorn Cancer Centre, St. Vincent's Hospital
Dec 13, 2021

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer Trial in Lexington, East Syracuse (TOL2506, Tamoxifen, Letrozole tablets)

Enrolling by invitation
  • Breast Cancer
  • Lexington, Kentucky
  • +1 more
Jan 9, 2023

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Breast Cancer Trial in Jakarta (Tamoxifen)

Active, not recruiting
  • Breast Cancer
  • Tamoxifen
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospitals Semanggi
Aug 12, 2022

Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston

Not yet recruiting
  • Male Breast Cancer
  • +2 more
  • Tamoxifen
  • +3 more
  • Boston, Massachusetts
  • +1 more
Aug 12, 2022